ABSTRACT. Melanogenesis cascade may be directly or indirectly linked to the dynamics of endosome-lysosome biogenesis. This study aims to identify how and to what extent the endosome-lysosome system is involved in melanosome biogenesis, by utilizing a novel melanogenesis marker, J1, which we identified in the process of developing monoclonal antibodies (MoAbs) against human melanosomes. The antigenic epitope of MoAb J1 was expressed by all of the melanotic and nonmelanotic cells examined. It was expressed primarily by granular structures located in regions proximal to the Golgi complex. Most of MoAb J1 positive granules were co-stained with melanogenic markers, tyrosinase or tyrosinase-related protein (TRP-1). The epitope of MoAb J1 was also coexpressed by most, but not all, of LGP85 (a lysosomal marker) positive granules in both melanoma and non-melanoma cells, indicating that MoAb J1 recognizes a subset of lysosomal vesicles. MoAb J1 did not, however, react with vesicles with late/early (syntaxin 8/ EEA1) endosomal markers. Further examination using fluorophore-labeled pepstatin, a marker of lysosomal luminal content, confirmed that MoAb J1 specifically recognizes the luminal surface of lysosomes. These results indicate that MoAb J1 possesses an antigen epitope that is expressed in the luminal component of prelysosomal granules which are involved in the biogenesis cascade common to both melanosomes and lysosomes. We suggest that tyrosinase family protein, tyrosinase and TRP-1 are transported to melanosomes from TGN via these prelysosomal granules after being transiently transported to late endosomes.
Melanosome biogenesis involves four stages of maturation with distinct morphological and biochemical characteristics that reflect the biogenesis process of structural and enzymatic proteins (tyrosinase family protein), which is followed subsequently by structural organization and melanin deposition in melanosomes. Two major groups of melanosomal proteins are involved in melanosome biogenesis. They are tyrosinase family protein and lysosome-associated membrane protein (LAMP) family. Tyrosinase family protein is glycosylated and assembled in the ER with the help of a molecular chaperone, calnexin (Toyofuku et al., 1999) . It is then transported from the trans-Golgi network (TGN) to melanosomes through intracellular transport vesicles (Jimbow et al., 2000a) . Our recent studies as well as those of others indicate that a number of intracellular transporters are involved in this melanogenesis cascade, including adaptor protein (AP3), a number of small guanosine triphosphate-binding proteins, including rab7, and phosphoinositide 3 kinase (Jimbow et al., 2000b) . We also reported recently that newly synthesized TRP-1 is transported from TGN to melanosomes via late endosomes (Jimbow et al., 2000a,b) .
While there are many common features in biogenesis process of lysosomes and melanosomes, the tyrosinase family protein is expressed exclusively in melanogenesis cascade. Furthermore, melanosomes represent unique morphological features that are different from lysosomes as seen in manifestation of ellipsoidal shape and internal structures composed of regularly striated filaments or lamellae (Jimbow et al., 1986) . Therefore, it is presumed that there must be biogenesis processes not only unique to either melanosomes or lysosomes but also common to these two organelles. It has been recently shown that many secretory cells possess proteins with targeting signals that regulate the for-mation of transport vesicles and their transport to and fusion with their destined organelles. Little is known, however, as to what membrane component is distinct or common to lysosomes and melanosomes.
The elucidation of the components in the biosynthesis and maturation process unique or common to melanosomes and lysosomes is important because this process may be exploited for the development of new therapeutic strategies in the treatment of cancer of melanocytes, malignant melanoma . Its alteration may also directly reflect the development of certain hyper-and hypopigmentation diseases, hence this characterization may provide the basis for developing better modalities for diagnosis and treatment of this class of disease.
To identify the common or unique membrane properties of melanosomes and lysosomes, this study sets out to characterize the epitope properties of MoAb J1 that recognizes granular structures common to biogenesis process of melanosomes and lysosomes. MoAb J1 was found to be expressed by both melanocytic cells (including amelanotic melanoma cells) and non-melanocytic cells. In melanocytic cells the antigenic epitope of MoAb J1 was found in the granular organelles around regions proximal to the Golgi complexes, not membranous ones, and these granules coexpressed both tyrosinase and tyrosinase-related protein (melanogenic markers) and LGP85 (a lysosomal marker). The granules, however, failed to show EEA1 (an early endosome marker) or syntaxin 8 (a late endosome marker). Importantly MoAb J1 positive granules also expressed pepstatin (a marker for luminal membrane protein of lysosomes). We suggested that the antigenic epitope of MoAb J1 is a marker being expressed in the luminal membrane of prelysosomal granules, not terminal lysosomes, common to the biogenesis of both melanosomes and lysosomes. Melanogenic proteins, tyrosinase and tyrosinase-related protein are then transported from TGN to melanosomes via MoAb J1-positive lysosomal granules after being transiently transported to late endosomes.
Materials and Methods

Cells
Human melanoma cells of three cell lines were used in this study. They included SK-MEL-23 and SK-MEL-24 melanotic and amelanotic cells that were kindly supplied by Dr. A. Houghton, Sloan Kettering Cancer Center, N.Y., N.Y., USA. Normal human fetal lung fibroblasts MRC5, MeWo human melanoma cells, HeLa cervical squamous carcinoma cells, HEK293 human embryonic kidney cells were purchased from ATCC. These cells were cultured in Dulbecco's modified Eagle's medium (Gibco BRL, Paisley, UK) under a humidified 5% CO2. The medium contained 5% fetal bovine serum (ICN Flow, Basingstoke, UK). For immunofluorescence experiments, the cells were grown on poly-L-lysine (10 mg/ml) coated cover slides in 12-well plates (Coster, N.Y., N.Y., USA).
MoAbs against human melanosomes
Preparation of melanosomal fractions from human melanoma tissue, immunization against melanosomal fraction and screening of hybridomas secreting antibodies were done as reported previously (Akutsu and Jimbow, 1986) . Briefly the crude melanosomal fraction was isolated from fresh autopsy melanoma tissues of lung and liver from a Japanese patient with acral lentiginous melanoma. It was further purified by using a sucrose density gradient cetrifugation as described previously . The detailed methods for the production of antibodies including immunization of mice and the screening of hybridoma cells were also described previously (Akutsu and Jimbow, 1986) . A hybridoma secreting MoAb J1 was subcloned three times from a crude clone of HMSA1 hybridoma cells by a limiting dilution as described previously (Akutsu and Jimbow, 1986) . The J1 secreting hybridoma cells were grown in the same culture condition as described above for the melanoma and non-melanoma cells except for use of RPMI 1640 medium.
Antibodies and other reagents
A mouse monoclonal anti-human tyrosinase antibody was purchased from Novocastra Laboratories Ltd. (Balliol Business Park West, UK). Anti-LGP85, a rabbit polyclonal antiserum, was a generous gift of Dr. H. Fujita at Kyushu University, Fukuoka, Japan. Anti-EEA-1 and syntaxin8 mouse MoAbs were from Transduction lab. (Los Angeles, CA, USA). Anti-human TRP-1 antibody was raised in rabbits as described elsewhere. Secondary antibodies conjugated to Alexa 488 were from Molecular Probes (Eugene, OR, USA). Purified J1 IgG was conjugated to Alexa 630 (Molecular Probes) according to the manufacture's protocol. BODYPY-FL conjugated pepstatin was obtained from Molecular Probes.
Immunofluorescence analysis
Culture cells were fixed and permeabilized with methanol (-20°C) for 4 min. Fixed cells are washed and blocked with PBS containing 0.5% (w/v) BSA and incubated with various antibodies for 20 min at room temperature. The coverslips were washed twice with PBS/ BSA for five min each and incubated with fluorophore-labeled secondary antibodies for 20 min. After three washes with PBS/ BSA, the coverslips were inverted and placed on a slide using Vectashield ® mounting medium (Vecta Laboratories Inc., CA, USA). The slides were viewed under immunofluorescent microscope : either Nikon Fluoview confocal laser scanning microscope, or Olympus upright microscope with an argon laser (Mitsubishi optiplex GXM 5133), or Carl Zeiss 510 inverted confocal laser scanning microscope using oil immersion lens (´100).
Indirect immunostaining using paraffin-embedded sections
Paraffin-embedded sections were deparaffinized in xylene, dehydrated in a graded alcohol series, and processed to indirect immuno-peroxidase staining by using biotinylated horse anti-mouse IgG antibody and diamino-benzidine tetrahydrochloride as described previously (Der et al., 1993) .
Results
To characterize the specificity of MoAb J1 in the tissue distribution, we examined 11 cases of malignant melanoma tumors (6 primary melanoma and 5 metastatic melanoma (3 lymph node and 2 skin metastases)) by immunohistochemistry. Among 11 cases of malignant melanoma, two cases revealed positive reactivity with MoAb J1 on large atypical tumor cells, i.e., an intransit skin metastatic lesion of melanoma (Fig. 1) and a primary lesion of nodular melanoma. In contrast nomal melanocytes revealed little or very weak reaction. The staining intensity of J1 positive cells was not uniform throughout the melanoma lesions, and tumor cells were admixed with areas of strong and weak reactivity (Fig. 1b, c) .
Next, we studied whether MoAb J1 specifically reacts with melanosome-associated structures on in vitro culture cells using indirect immunofluorescence method. Initially, we attempted various methods of fixation and noticed that MoAb J1 reactivity was completely abolished when cells were once treated with paraformaldehyde, indicating that the J1 epitope recognition includes the interaction with primary amines. The best reactivity was observed when cells were fixed with methanol at -20°C for 4 min. When MeWo cells, a melanotic melanoma cell line, were incubated with MoAb J1 and followed by incubation with Alexa 594-conjugated secondary antibody, intense granular staining was observed around regions proximal to the Golgi complex (Fig. 2) . Such structures also revealed co-staining with anti-tyrosinase (Fig. 2a) or anti-TRP-1 antibody (Fig. 2b) . However, it should be noted that, while most of TRP-1 or tyrosinase reactive vesicles appeared to contain J1 epitope, MoAb J1 also labeled vesicles which showed little or no reactivity to the two antibodies of melanocytic markers, particularly by TRP-1 (Fig. 2b) .
Similar observations were also made in another melanotic melanoma cell line, SK-MEL-23, by indirect immunofluorescence using MoAb J1 (Fig. 3a and b) . Again, when we compared the intracellular localization of the epitope of MoAb J1 with that of tyrosinase, most of tyrosinase positive granules recognized MoAb J1 (Fig. 3a) . However, consistent with the observation in Fig. 2 , there were J1-positive granules that were clearly not labeled by the anti-tyrosinase antibody.
While melanosomes and lysosomes in melanoma cells are closely related and share many marker proteins, there are some populations of vesicles lacking one of the two markers (Fig. 3c) . We thus reasoned that the observed overlapping pattern of MoAb J1 with melanosomal marker proteins may suggest the association of MoAb J1 epitope with lysosomes. We then compared the MoAb J1 staining pattern with that of a lysosomal membrane protein, LGP85. As expected, nearly all of MoAb J1-labeled granules were costained by anti-LGP85 antibody (Fig. 3b) . Interestingly, the lysosomal membrane protein was also found in the structures with little expression of MoAb J1 epitope. These results indicate that MoAb J1 recognizes a subset of lysosomal and melanosomal granules rather than mature terminal lysosomes or fully melanized mature melanosomes. If MoAb J1 epitope is specifically localized in lysosomeassociated organelles, any cells which do not contain melanosomes should be MoAb J1-positive. We hence examined MoAb J1 reactivity with a variety of non-melanocytic cells. As expected, granular structures similar to those observed in melanoma cells were intensely stained by MoAb J1 in MRC 5, HeLa and HEK293 cells (Fig. 4a) . Close examination of MoAb J1-positive signals in MRC5 revealed that the epitope was rather confined to the periphery of the vesicles (Fig. 4a inset) . To elucidate how these J1 epitope-containing structures relate to LPG85-labeled endosomal granules, we compared the two antibody staining patterns (Fig. 4b) . Interestingly, J1 epitope apparently resided at the granular edges of LGP85 containing vesiculo-tublular network (Fig.  4b inset) , consistent with the above described hypothesis.
Among the cells we tested, amelanotic melanoma cell line, SK-MEL-24, gave the most intense signal with MoAb J1. To further characterize the nature of MoAb J1 positive granules, we explored the possibility of co-staining with other endosomal membrane system in SK-MEL-24 cells. Co-staining of MoAb J1 with antibody against EEA1, which is a well-characterized marker of early endosomes, showed little co-localization of the two epitopes (Fig. 5a) . Similarly, the J1 staining pattern was clearly distinct from vesicles that were marked by the antibody against syntaxin 8 (Fig. 5b ) which is associated with late endosomes, demonstrating that the J1 epitope was excluded from the endosomal vesiculo-tubular network.
It is often observed that luminal contents and membrane components in lysosomes show distinct staining patterns, presumably due to different segregation mechanisms. We finally compared MoAb J1 epitope localization with that of lysosomal content protein, cathepsin D. However, the structures labeled by anti-cathepsin D antibody would include two populations of endosomal membranes because cathepsin D is synthesized as an inactive preform and slowly converted to the mature form before reaching the lysosomes. Hence we used fluorophore-labeled pepstatin to probe mature cathepsin D. When MoAb J1 positive granular structures were compared to the pepstatin labeled structures, we found that both signals resembled one another in large part (Fig. 5c) , with occasional segregation of both molecules in a single compartment (Fig. 5c, inset) . It should be noted that some vesicles containing cathepsin D do not express the J1 epitope. Taken together with the fact that the J1 epitope was confined to the peripheral part of the enlarged vesicles (Fig. 4a, inset) , we concluded that J1 specifically recognizes a luminal surface component of lysosomal granules, called prelysosomes.
Discussion
Biogenesis of melanosomes may follow a pathway similar or common to that of lysosomes. Since the initial proposal by Novikoff et al. in 1968 , this possibility has been reiterated by a number of investigators (Orlow, 1998; Jimbow et al., 2000) . It is now apparent that melanosomes and lysosomes possess many common features including the formation of the acid compartment inside. Lysosome-associated membrane proteins (LAMPs) are also considered to be present in the luminal membrane of melanosomes (Jimbow et al., 1997) . In lysosomes, newly synthesized luminal proteins that are specifically transported to a secretory pathway are recognized by the mannose-6-phosphate (M6P) receptor at TGN via their M6P tag. Lysosomal enzymes are ultimately delivered to lysosomes either by maturation of the prelysosomes or vesicular transport to or fusion with pre-existing lysosomes (Mullock et al., 1998; Karlsson et al., 1998) . It has been recently indicated that membrane proteins are targeted to lysosomes and melanosomes using the same or similar targeting motif, i.e., tyrosine-or di-leucine-based motifs, respectively (Vijayasaradhi et al., 1995; Jimbow et al., 2000a) . Calvo et al. (1999) characterized sorting determinants of tyrosinase, and found, using HeLa cells, that the cytoplasmic domain of tyrosinase was necessary not only for internalization to but also for its steady-state localization in late endosomes and lysosomes. Mutagenesis of two leucine residues within a conventional di-leucine motif of this enzyme is shown to ablate its late endosomal localization. However, overexpression studies disclosed that the properties of this di-leucine-based signal are distinguishable from those of CD3 gamma, suggesting that in non-pigmented cells, di-leucine signals in tyrosinase and CD3 gamma are recognized and sorted by distinct pathways to the late endosomes.
In reviewing Drosophila eye pigmentation and mouse coat color, Odorizzi et al. (1998) indicated that AP3 is bound to the cytoplasmic tail of tyrosinase through dileucine motif and is necessary in intracellular transport of tyrosinase from TGN to melanosomes. Importantly, Honing et al. (1998) found that AP3 binds weakly with cytoplasmic tails of other non-melanosomal membrane proteins containing di-leucine and/or tyrosine-based sorting signals. They only found a low affinity of tyrosinase-associated adaptors to a cytoplasmic tail of LAMP1 or lysosomal acid phosphatase, even though the interaction of AP1 or AP2 with LAMP1 or lysosomal acid phosphatase was high and dependent on the critical residues of their tyrosine-based sorting motifs. Thus the adaptor proteins for LAMPs appear to be different from AP3. Furthermore, Yang et al. recently reported that LAMP1 and LAMP2 were mislocalized to the cell surface when they genetically inactivated AP3 by using gene knockout technique in mice (Yang et al., 2000) .
Lysosomes are classified into at least two subsets, (a) terminal lysosomes that contain lysosomal acid phosphatase, but little membrane transport and (b) prelysosomal compartments that have a more dynamic membrane transport than terminal lysosomes. The latter compartment is believed to be a hybrid organelle between lysosomes and late endosomes, and formed by fusion of lysosomes and late endosomes. We have previously proposed, in the gene transfection study of TRP-1, that the previously designated "stage I melanosomes" are the granules related to late endosomes, to which TRP-1 must be delivered from TGN before being transported to melanosomes at later stages of maturation (Jimbow et al., 2000) . Recently, Roposo et al. (2001) found, by kinetic analysis of fluid phase uptake and immunogold labeling, that premelanosomal proteins segregated from endocytotic markers within an unusual endosomal compartment. They further indicated that premelanosomes and melanosomes represent a distinct lineage of organelles, separate from conventional endosomes and lysosomes within pigment cells. In the present study we found that there are transitional vacuoles, which can be identified by the expression of MoAb J1. Immunostaining using this MoAb J1 showed distinct staining patterns from other well-characterized marker proteins. J1 positive compartments were largely vesicular and appeared to be connected to the LGP85 containing vesiculo-tubular network (Fig. 4c) . Also, the MoAb J1 staining pattern was closely resembled mature cathepsin D distribution, as revealed by fluorophore-labeled pepstatin uptake. Because soluble lysosomal hydrolases are segregated and concentrated to form mature lysosomes in the prelysosomal compartments, the MoAb J1 epitope appears to share the property of a soluble molecule in lysosomes. While we were unable to exclude the presence of isolated vesicles without any tubular extensions containing LGP 85 but not the epitope of MoAb J1, at least the majority of J1-positive vesicles were found to be connected to vesiculo-tubular structures. Interestingly, when enlarged vesicles were closely examined as in Fig. 4a , the MoAb J1 signal was absent in the center of the granules, and ring-shaped structures were revealed. Considering that MoAb J1 did not react with some pepstatin-labeled vesicles, we concluded that the MoAb J1 epitope would be located at the luminal surface of the vesicular rims of immature lysosomes.
Initially, MoAb J1 was raised against highly purified melanosomes. Indeed, MoAb J1 stained the majority of the tyrosinase-and TRP-1-containing vesicles. Apparently, the structures that MoAb J1 identifies include precompartments of mature melanosomes. Therefore, we proposed that MoAb J1 may define a subcompartment of prelysosomal network, where soluble hydrolases are concentrated and melanosomes may be segregated from lysosomes. It was further concluded that the J1-positive vacuoles are related to prelysosomal granules to which the tyrosinase family protein is transiently transported from late endosomes (stage I melanosomes) before being transported to stage II melanosomes. Currently we are in the process of identifying the MoAb J1antigen epitope. So far, we have found that (a) MoAb J1 epitope contains a primary amino group, (b) extraction of MoAb J1 epitope from lysosomal membrane is partially resistant to detergents, and (c) at least MoAb J1 epitope is not an abundant molecule which could be identified by immunoprecipitation.
Our further characterization of the MoAb J1 antigenic epitope may help to elucidate not only the basic biology of melanosome and lysosome biogenesis but also the clinical manifestation of abnormal pigmentation in humans. A number of congenital pigmentary diseases have been reported to be associated with abnormal lysosomal aggregation of melanin pigment. In the café au lait macules of neurofibromatosis (type I), the melanocyte forms abnormal, giant pigment granules, called macromelanosomes (Jimbow et al., 1973) or melanin macroglobules which result from altered lysosome cascade (Horikoshi et al., 1982) . Malfunction or failure of lysosomal cascade and vesicular transport has been recently found to result in abnormal pigmentation (hypopigmentation of the skin and eye) and systemic defects in certain congenital diseases, such as HermanskyPudlak syndrome and Chediak-Higashi syndrome. Hermansky-Pudlak syndrome is associated with altered trafficking of lysosomal cascade due to mutations of b3A subunit of AP3 adaptor (Dell'Angelica et al., 1999) , and manifests bleeding diathesis due to a platelet storage pool defect and an accumulation of ceroid-like materials in cells. ChediakHigashi syndrome is associated with recurrent episodes of pyogenic infections due to giant, dysfunctional lysosomes and platelet dense body deficiency (Collier et al., 1985) . Our application of MoAb J1 may provide a new tool in characterizing abnormal lysosomal segregation and abnormal melanin pigmentation in these congenital diseases.
